Everforth Shares Rise After Unit Wins $115 Million U.S. Army AI Contract
By Anvee Bhutani
Everforth shares rose Tuesday morning after the company said its federal government unit won a three-year, $115 million contract to support the U.S. Army's Nautilus artificial intelligence research and development program.
Shares were recently up 7% at $23.09. The stock has lost around half its value over the past 12 months.
The company said its Everforth ECS unit will support the U.S. Army Combat Capabilities Development Command Army Research Laboratory under the contract, helping develop, test and integrate advanced AI technologies for military applications.
As the prime contractor on the program, Everforth ECS will conduct research, development, testing and evaluation of trusted AI technologies designed to accelerate the transition of AI capabilities from laboratory research to operational use.
The work will focus on AI development, software engineering, cybersecurity, systems integration and testing, with an emphasis on deploying secure AI capabilities that support decision-making in bandwidth- and compute-constrained operational environments.
Everforth said the award expands its role in defense AI research and mission integration while supporting the Army's efforts to scale trusted AI technologies across military operations.
Write to Anvee Bhutani at anvee.bhutani@wsj.com
(END) Dow Jones Newswires
July 28, 2026 11:21 ET (15:21 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
4 Stocks to Buy Before They Rise Further
2 Undervalued Stocks to Buy Before They Rebound
The 10 Best Companies to Invest in Now
The 10 Best Dividend Stocks
